nucleoside analog reverse transcriptase inhibitors
NRTIs May Offer ‘Substantial’ Alzheimer’s Protection
Scientists are calling for clinical trials to test the potential of HIV drugs to prevent Alzheimer’s disease.
JUNE 12, 2025
FDA Approves Symtuza, the First Complete Darunavir-Based, Single-Tablet Regimen for HIV
The FDA recently approved Janssen's Symtuza, the first complete darunavir-based, single-tablet regimen for the ...
JULY 19, 2018
Load more